New WHO surveillance protocol for viral hepatitis
The World Health Organization calls for better monitoring of viral hepatitis with the launch of a new protocol. The objective of the protocol is to improve the understanding of the link between viral hepatitis and the 2 main consequences: cirrhosis and hepatocellular carcinoma. Better understanding of linkages between viral hepatitis and liver cancer will be key to improving global and national policies and strategies to reduce deaths caused by both diseases.
The late presentation definition used in the protocol builds on a consensus definition developed in 2017 involving authors from CHIP

Read the full publication here:
Late presentation of chronic viral hepatitis for medical care: a consensus definition. Mauss et al.

Find the new WHO protocol for surveillance of viral hepatitis here 
Next Immunologic Colloquim 21 March

The next Immunologic Colloqium will take place 21 March 15:30-16:00 @ Rigshospitalet Department of Infectious Diseases.


HIV training and mentoring programme

CHIP has launched the HIV training and mentoring programme for Ukrainian doctors in collaboration with WHO Regional Office in Ukraine. During this week the Ukrainian doctors will visit different hospitals in Copenhagen Region and other health institutions to meet the infectious diseases specialists who will share their knowledge and present on international standards for HIV treatment and care. 

HIV MEDICINE special issue: Outcomes of the HepHIV 2017 Malta Conference
In February 2018 HIV Medicine launched a special issue on the Outcomes of the HepHIV 2017 Malta Conference. The special issue provides an overview of the results of the HepHIV Conference 2017 organised by HIV in Europe. 
Special Issue 
CROI 2018
Conference on Retroviruses and Oppertunistic Infections 4 -7 March 2018.
CHIP will be represented at CROI 2018 with 2 presentations.
Please find all presentations here 
Can hypothermia reduce organ dysfunction and mortality in patients with septic shock?
Read more about the results of the latest PERSIMUNE research which was published in Lancet Respiratory Medicine. 
New publication: Results from the Copenhagen Comorbidity in HIV Infection (COCOMO) Study
Marco Gelpi and collegues from the Copenhagen Comorbidity in HIV Infection (COCOMO) Study affiliated with PERSIMUNE recently reported data indicating that even well-treated and in particular older HIV-positive persons remains having a distrinct pro-atherogenic phenotype compared to age and gender matched sections of the general population. This observation renders supports for notions from other sections of research by CHIP and PERSIMUNE, that HIV status is an independent risk factor for cardiovascular disease.  Research focused on identifying mechanisms explaining the development of the phenotype and interventions to contract its likely adverse reactions is underway. 
PhD defence Camilla Hatleberg
Camilla Hatleberg will be defending her PhD Thesis on "Cardiovascular disease in HIV-positive persons: Changes and differences in mortality, -interventions and risk factors; the D:A:D Study"
28th February at 14:00 at Nielsine Nielsen auditoriet in the Mærsk Tower Faculty of Health and Medical Science, University of Copenhagen

Find more information here 
Wall of fame PERSIMUNE Data Warehouse
Acknowledgement of the huge work done in relation to the establishment of the PERSIMUNE Datawarehouse
See the Wall of Fame for the PERSIMUNE Data Warehouse

MISP - Talks: The new horizon in biomedicine
Join the MISP - Talks: The new horizon in biomedicine 
8 December 2017 16-19 
Jerne Auditorium in Mærsk Tower
The Panum Institute

Open to all, scientists and general public.
The MISP talks are a series of forward looking talks on precision
medicine and the emerging new science frontiers and technologies,
presented by leading international experts.

Please find full programme and register for the event here 
EACS Guidelines 9.0
In relation to the recent EACS conference in Milan, Version 9.0 of the EACS Guidelines was launched. The massive work in reviewing and updating the EACS Guidelines is led by Prof Manuel Battegay with the support of Dr. Lene Ryom from CHIP.
The guidelines are an essential tool for clinicians assisting their work in the fast evolving field of HIV treatment. Version 9.0 of the Guidelines includes revisions to the sections on antiretroviral treatment, co-morbidities, opportunistic infections and Hepatitis C.

Read more about the latest updates and the work around the EACS Guidelines here
Find the latest version of the EACS Guidelines here

EACS 2017
16th European AIDS Conference 25-27 October 2017, Milan, Italy

CHIP is represented with 7 presentations at EACS 2017, 2 oral presentations and 5 poster presentations

Please find all presentations HERE 
Available positions at CHIP
CHIP is looking to fill a position as Post Doc in biostatistics and is also hiring a student for our IT department. Read more about the positions HERE 
ID WEEK 2017 - San Diego 4-8 October 2017
CHIP will be represented at IDWEEK 2017 with 8 presentations. 
1 oral presentation and 7 poster presentations.

See all presentations here 
Launch of the Joint Action - INTEGRATE
19t September the Joint Action on integrating prevention, testing and link to care strategies across HIV, viral hepatitis, TB and STIs in Europe - INTEGRATE - will be launched.

INTEGRATE is funded by the 3rd EU Health Programme and will run over three years (September 2017-August 2020)

The main objective of INTEGRATE is to integrate early diagnosis and linkage to prevention and care of HIV, viral hepatitis, TB and STIs in EU member states by 2020.

Press Release from the European Commission

Read mroe about the Joint Action INTEGRATE here

For more information follow INTEGRATE on Facebook and Twitter

New EU project

CHIP will be the coordinator for the new EU funded Joint Action INTEGRATE. The launch of INTEGRATE will happen in Brussels 19 September 2017 where the EU commissioner for Food and Health will participate.
Read more here